Meet the Professor Lunch Sessions
We are delighted to invite you to informal lunch sessions with renowned AD/PD™ faculty members.
Kaj Blennow, Sweden
PROS AND CONS FOR DIFFERENT RATIOS FOR AMYLOID AND TAU BIOMARKERS IN CSF AND PLASMA
Ornit Chiba-Falek, USA
TRANSLATING INNOVATIVE DISCOVERIES INTO CLINICAL APPLICATIONS IN NEURODEGENERATION: OPPORTUNITIES AND CHALLENGES IN SPINNING-OUT A STARTUP FROM ACADEMIA
Henne Holstege, The Netherlands
RESILIENCE AND RESISTANCE, AND THE GENETICS BEHIND IT
Werner Poewe, Austria
ARE WE READY FOR PD RISK SCREENING?
Philip Scheltens, The Netherlands
HOW TO SET UP A MEMORY CLINIC?
Dennis Selkoe, USA
SCIENTIFIC AND REGULATORY CONTROVERSY AROUND THE AMYLOID HYPOTHESIS
Maria Grazia Spillantini, UK
UNDERSTANDING THE BIOLOGY TO CLASSIFY PD
Giovanni Frisoni, Switzerland
TREATING AND PREVENTING ALZHEIMER’S DISEASE
Sjors Scheres, UK
CRYO-EM OF AMYLOID FILAMENTS
Rhoda Au, USA
PUSHING FORWARD PROMISING SCIENCE: BEING 1ST VERSUS 10TH.
Marc Diamond, USA
RESEARCH ON DISEASE VS. BIOLOGICAL MECHANISMS: HOW DO I DEVELOP MY CAREER?
Christian Haass, Germany
DO WE NEED TO DEVELOP MICROGLIAL TREATMENT STRATEGIES?
William Jagust, USA
WHAT IS THE FUTURE ROLE OF PET IN ALZHEIMER’S DISEASE RESEARCH?”
Virginia Lee, USA
MISFOLDED PROTEINS IN NEURODEGENERATIVE DISEASES
Agneta Nordberg, Sweden
HOW TO WRITE A SUCCESSFUL GRANT APPLICATION? TO THINK OUF OF THE BOX?
Taylor Schmitz, Canada
MOVING TO ANOTHER COUNTRY FOR YOUR GRADUATE AND POSTGRADUATE RESEARCH: MAXIMIZING PROS AND MINIMIZING CONS.
BUILD TRANSDISCIPLINARY EXPERTISE IN A TRANSDISCIPLINARY FIELD
Jie Shen, USA
ALZHEIMER’S DISEASE MECHANISMS AND THERAPIES
Donna Wilcock, USA
TBA
Tony Wyss-Coray, USA
BRAIN AGING AND ALZHEIMER’S DISEASE
Costantino Iadecola, USA
THE CHANGING LANDSCAPE OF ALZHEIMER’S DISEASE IN THE ANTI-AMYLOID ERA
Frank LaFerla, USA
BUILDING A FOUNDATION OF SUCCESS FOR EARLY STAGE SCIENTISTS
Michelle Mielke, USA
CAREER DEVELOPMENT FOR WOMEN
Thomas Sudhof, USA
CAREER PLANNING OR SCIENCE INTEGRITY
Malu Tansey, USA
TARGETING IMMUNE DYSFUNCTION AND CHRONIC INFLAMMATION TO REDUCE RISK AND PROGRESSION OF NEURODEGENERATIVE DISEASES
Henrik Zetterberg, Sweden
PUBLISHING AND PEER REVIEW
Dag Aarsland, UK
DLB, PARKINSON AND COGNITION, PREVENTION OF AD, DIGITAL TECHNOLOGIES, CLINICAL USE OF BIOFLUID BIOMARKERS
Angela Genge, Canada
EVOLUTION OF CLINICAL OUTCOME MEASURES IN ALS
Todd Golde, USA
NAVIGATING AND ADVANCING YOUR CAREER, WHILE HAVING FUN DOING IT
Joanna Jankowsky, USA
STRENGTHS AND LIMITATIONS OF MOUSE MODELS FOR ALZHEIMER’S DISEASE.
Miia Kivipelto, Sweden
TBA
Tiago Outerio, Germany
UNDERSTANDING THE BIOLOGY TO CLASSIFY PD
Li-Huei Tsai, USA
TBA
Cheryl Wellington, Canada
LONG-TERM CONSEQUENCES OF BRAIN TRAUMA
Frank Longo, USA
TBA
There is no fee for joining these sessions, however pre-registration is required.
Please, note that for each session there are a maximum of 9 seats available and you can join only 1 session per day.
You can book your seat during the registration process or if you are already registered, please contact us at reg_adpd25@kenes.com.